Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures
Sponsor: Yale University
Listed as NCT04652375, this NA trial focuses on Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery and remains completed. Sponsored by Yale University, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Oct 2024 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2023 — Dec 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2022 — Feb 2023 [monthly]
Recruiting NA
-
Sep 2021 — Jan 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .